Certara Reports First Quarter 2025 Financial Results
RADNOR, PA— 2025 年 5 月 5 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development,…
Certara2025 年 5 月 5 日
Rare disease drug development: challenges, support and hopes for the future
Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…
Certara2025 年 4 月 29 日
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions
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 Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans…
Certara2025 年 4 月 24 日
Certara Announces Second Annual Certainty U.S. Event
Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…
Certara2025 年 4 月 22 日
Using cost-effectiveness models for smarter drug development and healthcare decisions
2025 年 4 月 14 日 Editor’s note: This is the second in a series of four articles…
Certara2025 年 4 月 14 日
FDA to phase out animal testing with AI and lab-based models
FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…
Certara2025 年 4 月 11 日
Delivering DSUR Excellence for Multinational Biopharma
A global leader in immuno-oncology approached us for support with over 50 simple to complex…
Certara2025 年 4 月 11 日
FDA plans to phase out animal testing requirements
Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…
Certara2025 年 4 月 10 日
Standardizing Real World Data in Rare Disease: ATHN’s Journey
Learn how Certara helped ATHN standardize Real World Data for regulatory submissions, advancing rare disease…
Certara2025 年 4 月 8 日
Building effective health economic models: key components for success
2025 年 3 月 28 日 Editor’s note: This is the first in a series of four articles…
Certara2025 年 3 月 28 日
